Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Confocal Laser Endomicroscopy in the Lower Urinary Tract
The study completed an evaluation of confocal laser endomicroscopy for assessing the lower urinary tract in patients with bladder cancer and…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer [Phase 2]
Phase II trial of pazopanib in combination with weekly paclitaxel in refractory urothelial cancer has completed, with results posted on 2017…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder [NA]
Clinical trial update reporting completion of a study evaluating neoadjuvant dasatinib followed by radical cystectomy for urothelial carcino…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine and split-dose cisplatin plus sorafenib in chemotherapy-naïve urothelial carcinoma of the bladder. The …
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating sorafenib in advanced or metastatic urothelial cancers of the urinary tract (including bladder, renal pelvis, and u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial evaluating VEGF Trap (aflibercept) in patients with recurrent, locally advanced, or metastatic urothelial cancers has comple…
-
CLINICAL_TRIALS research · 2013-10-28Clinical Trial Update: The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
Clinical trial update examining the role of pyruvate kinase M2 (PKM2) in the growth, invasion and drug resistance of bladder urothelial carc…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Arsenic Trioxide in Treating Patients With Urothelial Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide in patients with recurrent urothelial cancers (including bladder, renal pelvis, ureter,…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating trastuzumab for previously treated, locally advanced or metastatic urothelial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Pazopanib and Vinflunine in Urothelial Cancer of the Bladder [Phase 1, Phase 2]
Phase 1/2 clinical trial update of pazopanib and vinflunine in advanced urothelial carcinoma of the bladder after platinum therapy failure; …
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer [Phase 2]
This document reports the completion and results posting of a Phase II study of AZD4877, an anti-mitotic agent, in advanced bladder cancer a…
-
FDA approval · 2010-05-28FDA Approved: CYSVIEW — Original Application (Photocure Inc.)
CYSVIEW (hexaminolevulinate hydrochloride) was approved by the FDA as an imaging agent to be used with blue-light cystoscopy to help detect …